KIF23 is associated with a poor prognosis, basal subtypes and immunotherapy response in urothelial carcinoma. Nomura N, Sekino Y, Shigematsu Y, Kobayashi G, et al. Investig Clin Urol 2026;67:530-542.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nomura N, Sekino Y, Shigematsu Y, Kobayashi G, et al. KIF23 is associated with a poor prognosis, basal subtypes and immunotherapy response in urothelial carcinoma. Investig Clin Urol 2026;67:530-542.
PMID: 42990036